Jagsonpal Pharma introduces new product; shares rise

Jagsonpal Pharmaceuticals Ltd’s shares were up by 4.71 per cent after the company announced the launch of MemUp, a hormone replacement therapy (HRT) featuring a USFDA-approved combination of bioidentical estradiol and bioidentical progesterone in a single daily oral capsule. MemUp aims to address vasomotor symptoms of menopause, such as hot flashes, night sweats, and sleep issues.  […]

Continue Reading

SEBI panel proposes changes to BRSR framework

A SEBI committee has suggested changes to the BRSR, or Business Responsibility and Sustainability Reporting, framework.  ESG disclosures for the value chain will be applicable to the top 250 listed entities on a comply-or-explain basis from FY25.  The committee felt the definition of ‘value chain’ needed to be rationalised to cover only significant partners. Accordingly, value chain partners would be redefined […]

Continue Reading